Mechanisms of bronchopulmonary resistance in the lung
Achler, C.; von Wichert, P.
Der Internist 32(11): 640-646
1991
ISSN/ISBN: 0020-9554 PMID: 1769800 Document Number: 385303
Document emailed within 1 workday
Related Documents
Volm, M.; Mattern, J.; Efferth, T.; Pommerenke, E.W. 1992: Expression of several resistance mechanisms in untreated human kidney and lung carcinomas Anticancer Research 12(4): 1063-1067Sun, H.; Maglio, D.; Nicolau, D. 2004: Macrolide resistance in Streptococcus pneumoniae: mechanisms, patterns, and clinical implications of resistance Connecticut Medicine 68(9): 571-576
Díaz, P.C.; Alvarez Gavilán, Y.; de Armas Rodríguez, Y.; Bisset Lazcano, J.A. 2007: Determination of insecticide-resistance and resistance mechanisms of Blattella germanica (Dictyoptera: Blattellidae) Revista Cubana de Medicina Tropical 59(2): 159-165
Courcambeck, J.ér.ôm.; Bouzidi, M.; Perbost, R.ég.; Jouirou, B.; Amrani, N.; Cacoub, P.; Pèpe, G.ér.; Sabatier, J.-M.; Halfon, P. 2006: Resistance of hepatitis C virus to NS3-4A protease inhibitors: mechanisms of drug resistance induced by R155Q, A156T, D168A and D168V mutations Antiviral Therapy 11(7): 847-855
Kovalenko, V.L. 1974: Histoenzymological characteristics of some processes in the lung accompanying bronchopulmonary cancer Voprosy Onkologii 20(7): 22-28
Sakharova, A.E.; Matveeva, E.S.; Epifantseva, M.A.; Bodunkova, L.E. 1981: Gentamicin concentration in the blood and lung tissue of children with bronchopulmonary pathology Antibiotiki 26(5): 388-391
Fox, W.W. 1978: Bronchopulmonary dysplasia [respirator lung syndrome]: clinical course and outpatient therapy Pediatric Annals 7(1): 75; 78-79; 82-83 Passim
Fujita, F.; Fujita, M.; Fujita, M.; Sakamoto, Y. 1994: Acquired resistance and cross-resistance of gemcitabine to cisplatin or vindesine in human lung cancer xenografted in nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(16): 2749-2755
Volm, M.; Bak, M.; Mattern, J. 1988: Intrinsic drug resistance in a human lung carcinoma xenograft is associated with overexpression of multidrug-resistance DNA-sequences and of plasma membrane glycoproteins Arzneimittel-Forschung 38(8): 1189-1193
Malnick, G.; Pickoff, A.S.; Ferrer, P.L.; Peyser, J.; Bancalari, E.; Gelband, H. 1980: Normal pulmonary vascular resistance and left ventricular hypertrophy in young infants with bronchopulmonary dysplasia: an echocardiographic and pathologic study Pediatrics 66(4): 589-596
Saga, T. 2012: New mechanisms of quinolone resistance among Enterobacteriaceae: focused on plasmid-mediated quinolone resistance Nihon Rinsho. Japanese Journal of Clinical Medicine 70(2): 333-338
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Agapitov, L.I.; Belozerov, I.M.; Mizernitskiĭ, I.L. 2012: The endothelin-1 and von Willebrand factor in the development of lung hypertension in children with chronic bronchopulmonary pathology Klinicheskaia Laboratornaia Diagnostika 1: 11-13
Oguri, T.; Fujiwara, Y.; Ochiai, M.; Fujitaka, K.; Miyazaki, M.; Takahashi, T.; Yokozaki, M.; Isobe, T.; Ohune, T.; Tsuya, T.; Katoh, O.; Yamakido, M. 1998: Expression of lung-resistance protein gene is not associated with platinum drug exposure in lung cancer Anticancer Research 18(6a): 4159-4162
Frank, L. 1991: The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia or who already have developed chronic lung disease: a cautionary note Pediatrics 88(2): 413-416
Zuo, W.-s.; Wei, L.; Song, X.-r.; Wang, X.-w.; Wang, M.-y.; Wang, Y.-s.; Yu, Z.-y.; Bi, Y. 2006: The clinical significance of P-glycoprotein, lung resistance protein and multidrug resistance related protein expressions in infiltrating breast carcinoma tissues Zhonghua Yi Xue Za Zhi 86(44): 3142-3145
Baas, F.; Jongsma, A.P.; Broxterman, H.J.; Arceci, R.J.; Housman, D.; Scheffer, G.L.; Riethorst, A.; van Groenigen, M.; Nieuwint, A.W.; Joenje, H. 1990: Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line Cancer Research 50(17): 5392-5398
Maĭorov, V.M.; Mel'nikova, N.I.; Dovzhenko, V.S.; Krasnokutskiĭ, S.A. 2001: Prolonged artificial ventilation of the lungs in the complex treatment of children with bronchopulmonary diseases concomitant with primary pulmonary hypertension and lung tissue fibrosis Anesteziologiia i Reanimatologiia 1: 67-68
Zhang, Z.G.; Harstrick, A.; Rustum, Y.M. 1992: Mechanisms of resistance to fluoropyrimidines Seminars in Oncology 19(2 Suppl 3: 4-9
Saunders, P.P.; Muhs, M.A.; Arimilli, S. 1996: Mechanisms of resistance to 6-aminonicotinamide Anticancer Research 16(2): 843-848